Total (N = 24) | bvFTD (n = 5) | PCA (n = 8) | PPA (n = 7) | DLB (n = 3) | fFTD (n = 0) | fAD (n = 1) | Other (n = 0) | ||
---|---|---|---|---|---|---|---|---|---|
Decline in cognitive symptoms | 38% | 40% | 38% | 43% | 33% | - | 0% | - | |
Negative impact on behaviour or wellbeing | 50% | 80% | 38% | 29% | 100% | - | 0% | - | |
Loss ability to do things | 46% | 60% | 38% | 43% | 67% | - | 0% | - | |
General health affected negatively | 42% | 40% | 38% | 29% | 100% | - | 0% | - | |
Medication changes | 13% | 0% | 0% | 14% | 33 | - | 100% | - | |
Negative impact on support received | 54% | 40% | 63% | 57% | 33 | - | 100% | - | |
Reduced ability to connect with people socially | 74% | 40% | 88% | 83% | 67 | - | 100% | - |